Autoimmunity induced by chemicals

References

• Russell A. S. Drug-induced autoimmune disease. Clin. Immunol. Allergy 1981; 1: 57–76
   Google Scholar
• Dukor P. Expressions and mechanisms of pseudo-allergic reactivity: an introduction. PAR. Pseudo-Allergic Reactions. Involvement of Drugs and Chemicals 1982; 3: 1–17
   Google Scholar
• Homberg J. C. Auto-immunite induite par les medicaments. Particularites immunologiques et hypotheses etiopathogeniques. Presse Med. 1984; 13: 2755–2760
   PubMedGoogle Scholar
• Bigazzi P. E. Mechanisms of Chemical-Induced Autoimmunity. Immunotoxicology and Immunopharmacology, J. Dean, M. I. Luster, A. E. Munson, H. Amos. Raven Press, New York 1985; 277
   Google Scholar
• Dean J. H., Vos J. G. An Introduction to Immunotoxicology Assessment. Immunotoxicology of Drugs and Chemicals, J. Descotes. Elsevier, Amsterdam 1986; 3
   Google Scholar
• Rose N. R., Bigazzi P. E. The Autoimmune Diseases. Handbook Series in Clinical Laboratory Science. Section F: Immunology Vol. I, Part I, A. Baumgarten, F. F. Richards. CRC Press, West Palm Beach, Florida 1978; 319
   Google Scholar
• D'Angeljean J., Morel E., Feuillet-Fieux M. N., Raimond F., Vernet Der Garabedian B., Jacob L., Bach J. F. Myasthenie induite par la D-penicillamine. Etude des correlations immuno-cliniques dans 23 cases. Presse Med. 1985; 14: 2336–2340
   PubMedGoogle Scholar
• Street J. C. Pesticides and the Immune System. Immunologic Considerations in Toxicology, R. P. Sharma. CRC Press, Boca Raton, Florida 1981; 48
   Google Scholar
• Benson E. A., Healey L. A., Barron E. J. Insulin antibodies in patients receiving penicillamine. Amer. J. Med. 1985; 78: 857–860
   PubMed Web of Science ®Google Scholar
• Ericsson R. J., Andress J. M. Chemically Induced Autoimmunization in Male Rats. Immunology of Reproduction, K. Bratanov, R. G. Edwards, V. H. Vulchanov, V. Dikov, B. Somlev. Bulgarian Academy of Sciences, Sofia 1973; 123
   Google Scholar
• Hess E. V. Drug-related Lupus: The Same or Different. Systemic Lupus Erythematosus, R. G. Lahita. J. Wiley and Sons, New York 1987; 869
   Google Scholar
• Weinstein A. Laboratory Diagnosis of Drug-Induced Lupus. Systemic Lupus Erythematosus, R. G. Lahita. J. Wiley and Sons, New York 1987; 881
   Google Scholar
• Reidenberg M. M., Drayer D. E. Genetic Regulation of Drug Metabolism and Systemic Lupus Erythematosus. Systemic Lupus Erythematosus, R. G. Lahita. J. Wiley and Sons, New York 1987; 857
   Google Scholar
• Dubois E. L., Wallace D. J. Drugs that Exacerbate and Induce Systemic Lupus Erythematosus. Dubois' Lupus Erythematosus, D. J. Wallace, E. L. Dubois. Lea and Febiger, Philadelphia, PA 1987; 450
   Google Scholar
• Spears C. J., Batchelor J. R. Drug-induced autoimmune disease. Adv. Nephrol. 1987; 16: 219–230
   PubMedGoogle Scholar
• Smith C. I.E., Hammarstrom L. Immunologic abnormalities induced by D-penicillamine. PAR. Pseudo-Allergic Reactions 1985; 4: 138–180
   Google Scholar
• Howard-Lock H. E., Lock C. J.L., Mewa A., Kean W. F. D-penicillamine: chemistry and clinical use in rheumatic disease. Semin. Arthr. Rheum. 1986; 15: 261–281
   PubMed Web of Science ®Google Scholar
• Weinstein A. N.F. Rothfield and the Cooperative Systemic Studies of the Rheumatic Diseases Group, Lack of induction of antinuclear antibodies by D-penicillamine in rheumatoid arthritis: a controlled study. J. Rheumatol. 1986; 13: 308–312
   PubMed Web of Science ®Google Scholar
• Mach P. S., Brouilhet H., Amor B. D-penicillamine: a modulator of anti-DNA antibodies production. Clin. Exp. Immunol. 1986; 63: 414–418
   PubMed Web of Science ®Google Scholar
• Sharma R. P. Industrial Compounds and Modification of Immune Responses: Studies with Vinyl Chloride. Immunologic Considerations in Toxicology, R. P. Sharma. CRC Press, Boca Raton, Florida 1981; 80
   Google Scholar
• Descotes J. Immunotoxicology of Drugs and Chemicals. Elsevier, Amsterdam 1986; 359
   Google Scholar
• Sergott T. J., Limoli J. P., Baldwin C. M., Jr., Laub D. R. Human adjuvant disease, possible autoimmune disease after silicone implantation: a review of the literature, case studies, and speculation for the future. Plastic Reconstr. Surg. 1986; 78: 104–114
   PubMed Web of Science ®Google Scholar
• Gordon-Smith E. S. Immune Drug-Induced Blood Dyscrasias. Immunotoxicology, G. G. Gibson, R. Hubbard, D. V. Parke. Academic Press, New York 1983; 161
   Google Scholar
• Kelton J. G. Impaired reticulendothelial function in patients treated with methyldopa. New Engl. J. Med. 1985; 313: 596–600
   PubMed Web of Science ®Google Scholar
• Kleinman S., Nelson R., Smith L., Goldfinger D. Positive direct antiglobulin tests and immune hemolytic anemia in patients receiving procainamide. New Engl. J. Med. 1984; 311: 809–812
   PubMed Web of Science ®Google Scholar
• Logue G. L., Boyd A. E., Rosse W. F. Chlorpropamide-induced immune hemolytic anemia. New Engl. J. Med. 1970; 283: 900–904
   PubMed Web of Science ®Google Scholar
• Kornberg A., Kobrin I. IgG antiplatelet antibodies due to carbamazepine. Acta haemat. 1982; 68: 68–70
   PubMed Web of Science ®Google Scholar
• Von dem Borne A. E.G., Kr, Pegels J. G., Van der Stadt R. J., Van der Plas-van Dalen C. M., Helmerhorst F. M. Thrombocytopenia associated with gold therapy: a drug induced autoimmune disease. Brit. J. Haematol. 1986; 63: 509–516
   PubMed Web of Science ®Google Scholar
• Abdi E. A., Brien W., Venner P. M. Auto-immune thrombocytopoenia related to interferon therapy. Scand. J. Haematol. 1986; 36: 515–519
   PubMedGoogle Scholar
• Jaffe I. A. Induction of auto-immune syndromes by penicillamine therapy in rheumatoid arthritis and other diseases. Springer Semin. Immunopathol. 1981; 4: 193–207
   PubMed Web of Science ®Google Scholar
• Levy R. S., Fisher M., Alter J. N. Penicillamine: review and cutaneous manifestations. J. Amer. Acad. Dermatol. 1983; 8: 548–558
   PubMed Web of Science ®Google Scholar
• Jaffe I. A. Adverse effects profile of sulfhydryl compounds in man. Amer. J. Med. 1986; 80: 471–476
   PubMed Web of Science ®Google Scholar
• Kleinknecht D., Vanhille P. H., Morel-Maroger L., Kanfer A., Lemaitre V., Mery J. P., Laederich J., Callard P. Acute interstitial nephritis due to drug hypersensitivity. An up-to-date review with a report of 19 cases. Adv. Nephrol. 1983; 12: 277–308
   PubMedGoogle Scholar
• Adler S. G., Cohen A. H., Broder W. A. Hypersensitivity phenomena and the kidney: role of drugs and environmental agents. Amer. J. Kidney Dis. 1985; 5: 75–96
   PubMed Web of Science ®Google Scholar
• Fillastre J. P., Mery J. P., Morel-Maroger L., Kanfer A., Godin M. Drug-induced Glomerulonephritis. Proc. 8th Int. Congr. Nephrol., W. Zurukzoglu, M. Papadimitriou, M. Pyrpasopoulos, M. Sion, C. Zamboulis. University Studio, ThessalonikiGreece 1981; 745
   Google Scholar
• Druet P., Bernard A., Hirsch F., Weening J. J., Gengoux P., Mahieu P., Birkenland S. Immunologically mediated glomerulonephritis induced by heavy metals. Arch. Toxicol. 1982; 50: 187–194
   PubMed Web of Science ®Google Scholar
• Harrison D. J., Thomson D., McDonald M. K. Membranous glomerulonephritis. J. Clin. Pathol. 1986; 39: 167–171
   PubMed Web of Science ®Google Scholar
• Ntoso K. A., Tomaszewski J. E., Jimenez S. A., Neilson E. G. Penicillamine-induced rapidly progressive glomerulonephritis in patients with progressive systemic sclerosis: successful treatment of two patients and a review of the literature. Amer. J. Kidney Dis. 1986; 8: 159–163
   PubMed Web of Science ®Google Scholar
• Rehan A, Johnson K. IgM nephropathy associated with penicillamine. Amer. J. Nephrol. 1986; 6: 71–74
   PubMed Web of Science ®Google Scholar
• Lindqvist K. J., Makene W. J., Shaba J. D., Nantulya V. Immunofluorescence and electron miocroscopic studies of kidney biopsies from patients with nephrotic syndrome, possibly induced by skin lightening creams containing mercury. E. Afr. Med. J. 1974; 51: 168–169
   Google Scholar
• Contrino J., Marucha P., Ribaudo R., Ference R., Bigazzi P. E., Kreutzer D. L. Effects of mercury on human polymorphonuclear leukocyte function in vitro. Amer. J. Pathol., in press
   Google Scholar
• Joshi B. C., Dwivedi C., Powell A., Holscher M. Immune complex nephritis in rats induced by long-term oral exposure to cadmium. J. Comp. Path. 1981; 91: 11–15
   PubMed Web of Science ®Google Scholar
• Palosuo T., Milgrom F. Gold-Induced Autoimmune Reactions. Nephrotoxic Mechanisms of Drugs and Environmental Toxins, G. A. Porter. Plenum Medical Book Company, New York 1982; 409
   Google Scholar
• Tornroth T., Skrifvars B. Gold nephropathy prototype of membranous glomerulonephritis. Amer. J. Pathol. 1974; 75: 573–586
   PubMed Web of Science ®Google Scholar
• Watanabe I., Whittier F. C., Moore J., Cuppage F. E. Gold nephropathy. Ultrastructural, fluorescence, and microanalytic studies of two patients. Arch. Pathol. Lab. Med. 1976; 100: 632–635
   PubMed Web of Science ®Google Scholar
• Wooley P. H., Griffin J., Panayi G. S., Batchelor J. R., Welsh K. I., Gibson T. J. HLA-DR antigens and toxic reactions to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis. New Engl. J. Med. 1980; 303: 300–302
   PubMed Web of Science ®Google Scholar
• Wilson C. B. Drug and Toxin-Induced Nephritides. Anti-Kidney Antibody and Immune Complex Mediation. Nephrotoxic Mechanisms of Drugs and Environmental Toxins, G. A. Porter. Plenum Medical Book Company, New York 1982; 383
   Google Scholar
• Arnaiz-Villena A., Vicario J. L., Serrano-Rios M., Bellas C., Mamplaso F. Glomerular basement-membrane antibodies and HLA-DR2 in Spanish rapeseed oil disease. New Engl. J. Med. 1982; 307: 1404–1405
   PubMed Web of Science ®Google Scholar
• Safran M., Paul T. L., Roti E., Braverman L. E. Environmental factors affecting autoimmune thyroid disease. Endocrinol. Metabolism Clin. N. Amer. 1987; 16: 327–342
   PubMed Web of Science ®Google Scholar
• Deniker P., Eyquem A., Bernheim R., Loo H., Delarue P. Thyroid autoantibody levels during lithium therapy. Neuropsychobiology 1978; 4: 270–275
   PubMed Web of Science ®Google Scholar
• Calabrese J. R., Gulledge A. D., Hahn K., Skwerer R., Kotz M., Schumacher O. P., Gupta M. K., Krupp N., Gold P. W. Autoimmune thyroiditis in manic-depressive patients with lithium. Am. J. Psych. 1985; 142: 1318–1321
   PubMed Web of Science ®Google Scholar
• Myers D. H., Carter R. A., Burns B. H., Armond A., Huseein S. B., Chengapa U. K. A prospective study of the effects of lithium on thyroid function and on the prevalence of antithyroid antibodies. Psychol. Med. 1985; 15: 55–61
   PubMed Web of Science ®Google Scholar
• Hassman R. A., Lazarus J. H., Dieguez C., Weetman A. P., Hall R., McGregor A. M. The influence of lithium chloride on experimental autoimmune thyroid disease. Clin. Exp. Immunol. 1985; 61: 49–57
   PubMed Web of Science ®Google Scholar
• Kutcher S. P., Kadlubovski M. Are thyrotropin-binding inhibiting immunoglobulins associated with lithium-induced thyroid gland dysfunction. Biol. Psychiatry 1986; 21: 414–416
   PubMed Web of Science ®Google Scholar
• Nishiyama S., Matsukura M., Fujimoto S., Matsuda I. Reports of two cases of autoimmune thryoiditis while receiving anticonvulsant therapy. Eur. J. Pediatr. 1983; 140: 116–117
   PubMed Web of Science ®Google Scholar
• Rabinowe S. L., Larsen P. R., Antman E. M., George K. L., Friedman P. L., Jackson R. A., Eisenbarth G. S. Amiodarone therapy and autoimmune thyroid disease. Increase in a new monoclonal antibody-defined T cell subset. Amer. J. Med. 1986; 81: 53–57
   PubMed Web of Science ®Google Scholar
• Monteiro E., Galvao-Teles A., Santos M. L., Mourao L., Correia M. J., Tuna J. L., Ribeiro C. Antithyroid antibodies as an early marker for thyroid disease induced by amiodarone. Brit. Med. J. 1986; 292: 227–228
   PubMed Web of Science ®Google Scholar
• Ch B. H. Stricker Hepatic injury by drugs and environmental agents. Liver Ann. 1986; 5: 419–482
   Google Scholar
• Neuberger J., Davis M. Immune mechanisms in drug-induced liver injury. Recent Adv. Hepatol. 1983; 1: 89–100
   Google Scholar
• Homberg J. C., Abuaf N., Helmy-Khalil S., Biour M., Poupon R., Islam S., Darnis F., Levy V. G., Opolon P., Beaugrand M., Toulet J., Danan G., Benhamou J. P. Drug-induced hepatitis associated with anticytoplasmic organelle autoantibodies. Hepatology 1985; 5: 722–727
   PubMed Web of Science ®Google Scholar
• Beaune P., Dansette P. M., Mansuy D., Kiffel L., Finck M., Amar C., Leroux J. P., Homberg J. C. Human anti-endoplasmic reticullum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P–450 that hydroxylates the drug. Proc. Natl. Acad. Sci. USA 1987; 84: 551–555
   PubMed Web of Science ®Google Scholar
• Cochrane A. M.G., Moussouros A., Eddleston A. L.W.F., Williams R. Autoimmune reactions in alcohol-induced liver disease. Immune Reactions in Liver Disease, A. L.W.F. Eddleston, J. C.P. Weber, R. Williams. Pitman Medical Books, London 1979; 208–213
   Google Scholar
• Johnson R. J., Williams R. Genetic and environmental factors in the individual susceptibility to the development of alcoholic liver disease. Alcohol Alcohol. 1985; 20: 137–160
   PubMed Web of Science ®Google Scholar
• Mackay I. R. Induction by drugs of hepatitis and autoantibodies to cell organelles: significance and interpretation. Hepatology 1985; 5: 904–906
   PubMed Web of Science ®Google Scholar
• Wachsmuth E. D. Evaluating Immunopathological Effects of New Drugs. Immunotoxicology, G. G. Gibson, R. Hubbard, D. V. Parke. Academic Press, New York 1983; 237
   Google Scholar
• Ten Veen J. H., Feltkamp-Vroom T. M. Studies on drug-induced lupus erythematosus in mice. III. Renal lesions and splenomegaly in drug-induced lupus erythematosus. Clin. Exp. Immunol 1973; 15: 591–600
   PubMed Web of Science ®Google Scholar
• Tannen R. H., Weber W. W. Antinuclear antibodies related to acetylator phenotype in mice. J. Pharmacol. Exper. Ther. 1980; 213: 485–490
   PubMed Web of Science ®Google Scholar
• Malinow M. R., Bardana E. J., Pirofsky B., Craig S., McLaughlin P. Systemic Lupus Erythematosus-like syndrome in monkeys fed alfalfa sprouts: role of a nonprotein amino acid. Science 1982; 216: 415–417
   PubMed Web of Science ®Google Scholar
• Bardana E. J., Malinow M. R., Houghton D. C., McNulty W. P., Wuepper K. D., Parker F., Pirofsky B. Diet-induced Systemic Lupus Erythematosus (SLE) in primates. Amer. J. Kidney Dis. 1982; 1: 345–352
   PubMed Web of Science ®Google Scholar
• Prete P. E. The mechanism of action of L-canavanine in inducing autoimmune phenomena. Arthr. Rheum. 1985; 28: 1198–1200
   PubMed Web of Science ®Google Scholar
• Aucoin D. P., Peterson M. E., Hurvitz A. I., Drayer D. E., Lahita R. G., Quimby F. W., Reidenberg M. M. Propylthiouracil-induced immune mediated disease in the cat. J. Pharmacol. Exper. Ther. 1985; 234: 13–18
   PubMed Web of Science ®Google Scholar
• Smith C. I.E., Hammarstrom L., Matell G., Nilsson B. Y. Role of penicillamine for the induction of myasthenia gravis. Eur. Neurol. 1983; 22: 272–282
   PubMed Web of Science ®Google Scholar
• Donker A. J., Venuto R. C., Vladutiu A. O., Brentjens J. R., Andres G. A. Effects of prolonged administration of D-penicillamine or captopril in various strains of rats. Brown Norway rats treated with D-penicillamine develop autoantibodies, circulating immune complexes, and disseminated intravascular coagulation. Clin. Immunol. Immunopathol. 1984; 30: 142–155
   PubMedGoogle Scholar
• Weening J. J., Hoedemaeker Ph. J., Bakker W. W. Immunoregulation and anti-nuclear antibodies in mercury-induced glomerulopathy in the rat. Clin. Exp. Immunol. 1981; 45: 64–71
   PubMed Web of Science ®Google Scholar
• Weening J. J., Fleuren G. J., Hoedemaeker Ph. J. Demonstration of anti-nuclear antibodies in mercuric chloride-induced glomerulopathy in the rat. Lab. Invest. 1978; 39: 405–411
   PubMed Web of Science ®Google Scholar
• Goter Robinson C. J., Abraham A. A., Balazs T. Induction of antinuclear antibodies by mercuric chloride in mice. Clin. Exp. Immunol. 1984; 58: 300–306
   PubMed Web of Science ®Google Scholar
• Kolb H., Toyka K. V., Gleichmann E. Histocompatibility antigens and chemical reactivity in autoimmunity. Immunol Today 1987; 8: 3–6
   PubMedGoogle Scholar
• Weening J. J., Grond J., Van der Top D., Hoedemaeker Ph. J. Identification of the nuclear antigen involved in mercury-induced glomerulopathy in the rat. Invest. Cell. Path. 1980; 3: 129–134
   PubMedGoogle Scholar
• Heremans H., Billiau A., Colombatti A., Hilgers J., De Somer P. Interferon treatment of NZB mice: accelerated progression of autoimmune disease. Infection Immun. 1978; 21: 925–930
   PubMed Web of Science ®Google Scholar
• Russell A. S., Lindstrom J. M. Penicillamine-induced myasthenia gravis associated with antibodies to acetylcholine receptor. Neurology 1978; 28: 847–849
   PubMed Web of Science ®Google Scholar
• Aldrich M. S., Yong I. K., Sanders D. B. Effects of D-penicillamine on neuromuscular transmission in rats. Muscle Nerve 1979; 2: 180–185
   PubMed Web of Science ®Google Scholar
• Burres S. A., Kanter M. E., Richman D. P., Arnason B. G.W. Studies on the pathophysiology of chronic D-penicillamine-induced myasthenia. Ann. N.Y. Acad. Sci. 1981; 377: 640–650
   PubMed Web of Science ®Google Scholar
• McVicker J. H., Lava N. S., Mittag T. W., Ringel S. P. d-penicillamine-induced neuromuscular disease in guinea pigs. Exper. Neurol. 1982; 76: 46–57
   PubMed Web of Science ®Google Scholar
• Bever C. T., Dretchen K. L., Blake G. J., Chang H. W., Penn A. S., Asofsky R. Augmented anti-acetylcholine receptor response following long-term penicillamine administration. Ann. Neurol. 1984; 16: 9–13
   PubMed Web of Science ®Google Scholar
• Roman-Franco A. A., Turiello M., Albini B., Ossi E., Milgrom F., Andres G. A. Anti-basement membrane antibodies and antigen-antibody complexes in rabbits injected with mercuric chloride. Clin. Immunol. Immunopathol. 1978; 9: 464–481
   PubMedGoogle Scholar
• Druet P., Druet E., Potdevin F., Sapin C. Immune type glomerulonephritis induced by HgCl2 in the Brown-Norway rat. Ann. Immunol. (Inst. Pasteur) 1978; 129C: 777–792
   Google Scholar
• Druet P., Sapin C., Druet E., Hirsch F. Genetic Control of Mercury-Induced Immune Response in the Rat. Nephrotoxic Mechanisms of Drugs and Environmental Toxins, G. A. Porter. Plenum Medical Book Company, New York 1982; 425
   Google Scholar
• Michaelson J. H., McCoy J. P., Jr., Hirszel P., Bigazzi P. E. Mercury-induced autoimmune glomerulonephritis in inbred rats, I. Kinetics and species specificity of autoimmune responses. Surv. Synth. Path. Res. 1985; 4: 401–411
   PubMedGoogle Scholar
• Bernard A., Lauwerys L., Gengoux P., Mahieu P., Foidart J. M., Druet P., Weening J. J. Anti-laminin antibodies in Sprague-Dawley and Brown-Norway rats chronically exposed to cadmium. Toxicology 1984; 31: 307–313
   PubMed Web of Science ®Google Scholar
• Ueda S., Wakashin M., Wakashin Y., Yoshida H., Iesato K., Mori T., Mori Y., Akikusa B., Okuda K. Experimental gold nephropathy in guinea pigs: detection of autoantibodies to renal tubular antigens. Kidney Int. 1986; 29: 539–548
   PubMed Web of Science ®Google Scholar
• Yamamoto T., Wilson C. B. Binding of anti-basement membrane antibody to alveolar basement membrane after intratracheal gasoline instillation in rabbits. Amer. J. Pathol. 1987; 126: 497–505
   PubMed Web of Science ®Google Scholar
• Albini B., Glurich I., Andres G. A. Mercuric Chloride-Induced Immunologically Mediated Diseases in Experimental Animals. Nephrotoxic Mechanisms of Drugs and Environmental Toxins, G. A. Porter. Plenum Medical Book Company, New York 1982; 413
   Google Scholar
• Enestrom S., Hultman P. Immune-mediated glomerulonephritis induced by mercuric chloride in mice. Experientia 1984; 40: 1234–1240
   PubMedGoogle Scholar
• Shull R. M., Stowe C. M., Osborne C. A., O'Leary T. P., Vernier R. L., Hammer R. F. Membranous glomerulonephropathy and nephrotic syndrome associated with iatrogenic metallic mercury poisoning in a cat. Vet. Hum. Toxicol. 1981; 23: 1–5
   PubMedGoogle Scholar
• Strunk S. W., Ziff M. Ultrastructural studies of the passage of gold thiomalate across the renal glomerular capillary wall. Arthr. Rheum. 1970; 13: 39–52
   PubMed Web of Science ®Google Scholar
• Nagi A. H., Alexander F., Barabas A. Z. Gold nephropathy in rats-light and electron microscopic studies. Exper. Molec. Pathol. 1971; 15: 354–362
   PubMed Web of Science ®Google Scholar
• Nagi A. H., Kahn A. H. Gold nephropathy in rabbits using an indigenous preparation. A morphological study. Int. Urol. Nephrol. 1984; 16: 49–59
   PubMedGoogle Scholar
• Lewis R. E., Cruse J. M., Johnson W. W., Mohammad A. Histopathology and cell-mediated immune reactivity in halothane-associated lymphomagenesis and autoimmunity in BXSB/Mp and MRL/Mp mice. Exper. Molec. Pathol. 1982; 36: 378–395
   PubMed Web of Science ®Google Scholar
• Seelig H. P., Seelig R., Fischer A., Maurer R., Safer A., Schnitzlein W. Immunkomplex-Glomerulonephritis nach peroraler Penicillamin-Applikation bei Ratten. Res. exp. Med. 1977; 170: 35–55
   Google Scholar
• Gresser I., Morel-Maroger L., Chatelet F., Maury C., Tovey M., Bandu M.-T., Buywid J., Delauche M. Delay in growth and the development of nephritis in rats treated with interferon preparations in the neonatal period. Amer. J. Pathol. 1979; 95: 329–340
   PubMed Web of Science ®Google Scholar
• Kitchen D. N., Todd G. C., Meyers D. B., Paget C. Rat lymphocytic thyroiditis associated with ingestion of an immunosuppressive compound. Vet. Pathol. 1979; 16: 722–729
   PubMed Web of Science ®Google Scholar
• Remy J. J., Salamero J., Michel-Bechet M., Charreire J. Experimental autoimmune thyroiditis induced by recombinant interferon-gamma. Immunol. Today 1987; 8: 73
   PubMedGoogle Scholar
• McConahey W. M., Keating F. R., Bealis O. H., Wollner L. B. On the increasing occurrence of Hashimoto's thyroiditis. J. Clin. Endocrin. Metab. 1962; 22: 542–544
   Web of Science ®Google Scholar
• Glass D., Shur P. Autoimmunity and Systemic Lupus Erythematosus. Autoimmunity, N. Talal. Academic Press, New York 1977; 532–568
   Google Scholar
• Tan E. M. Drug-induced autoimmune disease. Fed. Proc. 1974; 33: 1894–1897
   PubMedGoogle Scholar
• Yamauchi Y., Litwin A., Adams L., Zimmer H., Hess E. V. Induction of antibodies to nuclear antigens in rabbits by immunization with hydralazine-human serum albumin conjugate. J. Clin. Invest. 1975; 56: 958–969
   PubMed Web of Science ®Google Scholar
• Nagata N., Hurtenback U., Gleichmann E. Specific sensitization of Lyt-I+2− T cells to spleen cells modified by the drug d-penicillamine or a stereoisomer. J. Immunol. 1986; 136: 136–142
   PubMed Web of Science ®Google Scholar
• Kirtland H. H., Mohler D. N., Horwitz D. A. Methyldopa inhibition of suppressor-lymphocyte function: a proposed cause of autoimmune hemolytic anemia. New Engl. J. Med. 1980; 302: 825–832
   PubMed Web of Science ®Google Scholar
• Bluestein H. G., Redelman D., Zvaifler N. J. Procainamide-lymphocyte reactions. Arthr. Rheum. 1981; 24: 1019–1023
   PubMed Web of Science ®Google Scholar
• Ochi T., Goldings E. A., Libsky P. E., Ziff M. Immunomodulatory effect of procainamide in man. Inhibition of human suppressor T-cell activity in vitro. J. Clin. Invest. 1983; 71: 36–45
   PubMed Web of Science ®Google Scholar
• Miller K. B., Salem D. Immune regulatory abnormalities produced by procainamide. Amer. J. Med. 1982; 73: 487–492
   PubMed Web of Science ®Google Scholar
• Duggan M. A.K., Court J. B. A proposed mechanism of production of the autoimmune and lymphoproliferative side effects of beta-adrenergic-site-blocking drugs and hydatoin anticonvulsants. Ann. Clin. Res. 1981; 13: 406–418
   PubMedGoogle Scholar
• Bigazzi P. E. Anti-idiotypic immunity in autoimmunity. Ann. N.Y. Acad. Sci. 1986; 475: 66–80
   PubMedGoogle Scholar